Considering the role of TCF7L2 risk variants in insulin secretion, Pearson et al. [15] hypothesized that patients with diabetes risk alleles at rs12255372 and rs7903146 have an altered hypoglycaemic response to sulfonylureas (SUs) due to decreased β-cell function. The gene discussed is INS; the disease is diabetes mellitus.